TLR9 and myopathy: Arguing that activation of TLR9-mediated inflammation is a general response to loss of mitochondrial fusion, loss of the inner mitochondrial membrane fusion protein OPA1 in muscle leads to TLR9-mediated NF‐κB activation (but not cGAS-STING), where it also drives an inflammatory myopathy (19).